ICU drug tested as potential sleep aid for PTSD nightmares
NCT ID NCT06685965
Summary
This study is testing whether a low dose of a medication called dexmedetomidine, which is already used to sedate patients in intensive care, can help people with PTSD sleep better. Twenty-four adults with PTSD and ongoing sleep problems will spend three nights in a sleep lab, trying either a low dose, a high dose, or a placebo, without knowing which one they are getting. The main goal is to see if the medication safely increases the amount of deep, restorative sleep they get.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTTRAUMATIC STRESS DISORDER (PTSD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Human Sleep Pharmacology, University of Zurich
RECRUITINGZurich, Canton of Zurich, 8057, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.